Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension (2009)
- Authors:
- USP affiliated authors: BENDHACK, LUSIANE MARIA - FCFRP ; GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FCFRP; FORP; FMRP
- DOI: 10.1016/j.freeradbiomed.2009.02.011
- Subjects: METALOPROTEINASES; RADICAIS LIVRES; ANTIOXIDANTES; HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Free Radical Biology and Medicine
- ISSN: 0891-5849
- Volume/Número/Paginação/Ano: v. 46, n. 9, p. 1298-1307, 2009
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: publisher-specific-oa
-
ABNT
CASTRO, Michele Mazzaron de et al. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radical Biology and Medicine, v. 46, n. 9, p. 1298-1307, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2009.02.011. Acesso em: 23 abr. 2024. -
APA
Castro, M. M. de, Rizzi, E., Rodrigues, G. J., Ceron, C. S., Bendhack, L. M., Gerlach, R. F., & Santos, J. E. T. dos. (2009). Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radical Biology and Medicine, 46( 9), 1298-1307. doi:10.1016/j.freeradbiomed.2009.02.011 -
NLM
Castro MM de, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Santos JET dos. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension [Internet]. Free Radical Biology and Medicine. 2009 ; 46( 9): 1298-1307.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2009.02.011 -
Vancouver
Castro MM de, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Santos JET dos. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension [Internet]. Free Radical Biology and Medicine. 2009 ; 46( 9): 1298-1307.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2009.02.011 - Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
- Evaluation of aortic metalloproteinase-2 (MMP-2) activity in two kidney one clip (2K1C) hypertension rats
- Metalloproteinase inhibition ameliorates hypertension and reverses vascular dysfunction and remodeling in renovascular hypertensive rats
- Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats
- Increased activity of matrix metalloproteinase-2(MMP-2) induced by reactive oxygen species (ROS) in two-kidney one-clip (2K1C) hypertension
- Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
- Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
- Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings
- Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
Informações sobre o DOI: 10.1016/j.freeradbiomed.2009.02.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
